explore -WSS

explore

author：hotspot 2025-10-01 11:02:43 - browse：5352

In a surprise move, the Food and Drug Administration has called for a meeting of outside advisers to discuss whether an Alzheimer’s drug from Eli Lilly should be approved, even as many outsiders expected the medicine to receive regulatory clearance this month.

The drug, donanemab, succeeded in its Phase 3 trial, resulting in a 35% slowing of Alzheimer’s disease progression versus placebo. But Lilly on Friday said that the FDA expects to call a meeting of an advisory committee to review the trial, saying that the agency had told the company “it wants to further understand topics related to evaluating the safety and efficacy of donanemab, including the safety results in donanemab-treated patients and the efficacy implications of the unique trial design” of the study.

A date for the meeting has not been set yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： TikTok cracks down on users posting about weight loss drugs

WSS

Bacterial infection may be ‘key event’ in endometriosis, study says

Make 'food is medicine' a key part of White House nutrition meeting

DOJ, FTC to increase scrutiny of all types of health care mergers

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Grail is spending more than ever lobbying Congress

Listen: Biogen's messy board & Laronde's data problem

entertainment

explore

entertainment

Drug repurposing or repositioning? The language matters

Researchers separate signal from noise in heart wearable data

Walensky prepares to leave CDC — and Congress — behind

PhRMA sues HHS over Medicare drug price negotiation

Malaria cases in Florida and Texas: Here’s what you need to know

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

In age of alternative facts, a scholarly course on calling out crap

Grail is spending more than ever lobbying Congress

Walensky prepares to leave CDC — and Congress — behind

Plane’s emergency slide plummets from sky, hits Chicago home

explore

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Inside the fall of star MIT scientist David Sabatini

4th of July breaks record for highest global temperature ever measured

Medical experts are missing from AI regulatory conversations

Did the public have the right to know Arthur Ashe had AIDS?

explore

Wikipedia

Wikipedia

explore